ArticleFrontiers in immunology2023

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces

Kacy S Yount et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.